We are live on
!
Find out more
E
Ergoteles Portfolio holdings
AUM
$68.2M
1-Year Est. Return
36.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.32%
1 Year Est. Return
+36.16%
3 Year Est. Return
+76.43%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.72B
AUM Growth
-$123M
(-4.3%)
Cap. Flow
-$215M
Cap. Flow
% of AUM
-7.9%
Top 10 Holdings %
Top 10 Hldgs %
16.65%
Holding
2,200
New
704
Increased
294
Reduced
353
Closed
800
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$85.8M |
| 2 |
Steel Dynamics
STLD
|
+$50.2M |
| 3 |
McKesson
MCK
|
+$43.7M |
| 4 |
STOR
STORE Capital Corporation
STOR
|
+$38.2M |
| 5 |
Arch Capital
ACGL
|
+$26M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTXS
Citrix Systems Inc
CTXS
|
+$149M |
| 2 |
DRE
Duke Realty Corp.
DRE
|
+$147M |
| 3 |
NLSN
Nielsen Holdings plc
NLSN
|
+$44.3M |
| 4 |
CoStar Group
CSGP
|
+$44.2M |
| 5 |
Chevron
CVX
|
+$43.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 15.28% |
| 2 | Healthcare | 12.35% |
| 3 | Industrials | 12.24% |
| 4 | Technology | 10.34% |
| 5 | Consumer Discretionary | 10.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
United Natural Foods
UNFI
$2.97B
| $269K | 0.01% |
+6,940
| New | +$287K |
|
|
BHR
952
Braemar Hotels & Resorts
BHR
$157M
| $268K | 0.01% |
65,204
-13,614
| -17% | -$55.9K |
|
953
HireQuest
HQI
$192M
| $268K | 0.01% |
16,935
-6,848
| -29% | -$108K |
|
954
Aramark
ARMK
$15.2B
| $268K | 0.01% |
8,966
-15,639
| -64% | -$431K |
|
955
Cleveland-Cliffs
CLF
$6.99B
| $267K | 0.01% |
+16,597
| New | +$250K |
|
956
Seres Therapeutics
MCRB
$47M
| $267K | 0.01% |
+2,384
| New | +$320K |
|
|
LIBY
957
DELISTED
Liberty Resources Acquisition Corp. Class A Common Stock
LIBY
| $267K | 0.01% |
+26,154
| New | +$265K |
|
958
Envoy Medical
COCH
$51.9M
| $267K | 0.01% |
26,400
| – | – |
|
|
NSTD
959
DELISTED
Northern Star Investment Corp. IV
NSTD
| $266K | 0.01% |
26,440
| – | – |
|
960
Insight Enterprises
NSIT
$3.71B
| $265K | 0.01% |
2,644
-3,737
| -59% | -$357K |
|
961
Jackson Financial
JXN
$8.44B
| $264K | 0.01% |
7,591
-48,909
| -87% | -$1.7M |
|
962
James River Group Holdings
JRVR
$217M
| $264K | 0.01% |
+12,623
| New | +$290K |
|
963
AEON Biopharma
AEON
$11.5M
| $262K | 0.01% |
+363
| New | +$260K |
|
964
Dominion Energy
D
$61.8B
| $261K | 0.01% |
+4,255
| New | +$267K |
|
|
ABGI
965
DELISTED
ABG Acquisition Corp. I
ABGI
| $260K | 0.01% |
25,719
-3,410
| -12% | -$34.1K |
|
966
Ezcorp Inc
EZPW
$1.87B
| $259K | 0.01% |
+31,782
| New | +$283K |
|
967
Vulcan Materials
VMC
$36.9B
| $257K | 0.01% |
1,467
-23,278
| -94% | -$3.98M |
|
968
Lamar Advertising Co
LAMR
$16.3B
| $256K | 0.01% |
+2,716
| New | +$251K |
|
969
Metallus
MTUS
$869M
| $256K | 0.01% |
14,105
-3,685
| -21% | -$65.4K |
|
970
Acuity Brands
AYI
$10.1B
| $255K | 0.01% |
1,542
-18,735
| -92% | -$3.33M |
|
971
Par Pacific Holdings
PARR
$3.94B
| $254K | 0.01% |
+10,940
| New | +$238K |
|
972
REX American Resources
REX
$1.44B
| $254K | 0.01% |
+15,944
| New | +$240K |
|
973
Innospec
IOSP
$2.11B
| $254K | 0.01% |
2,465
-681
| -22% | -$69.1K |
|
974
Stoke Therapeutics
STOK
$1.83B
| $253K | 0.01% |
+27,408
| New | +$285K |
|
975
ATN International
ATNI
$364M
| $253K | 0.01% |
+5,577
| New | +$244K |
|
Similar funds
ROC
IVMX
AM
JCG
JAMONY
FA
VCM
MCMI
Ergoteles's Q4 2022 Portfolio in Review
As of Q4 2022, Ergoteles held 2,200 positions worth $2.72B, down 4.3% from $2.85B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Ergoteles withdrew a net $215M in Q4 2022, closing 800 positions and reducing 353 holdings. Its most notable exit was Citrix Systems Inc, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, Ergoteles opened a new position in McKesson worth $43.9M.
- Ergoteles's largest Q4 2022 buy was McKesson: 117,079 shares worth $43.9M.
- Ergoteles added most to iShares Biotechnology ETF in Q4 2022, an estimated $85.8M increase.
- Ergoteles's biggest Q4 2022 reduction was Alphabet (Google) Class C, cutting an estimated $41.8M.
- Ergoteles fully exited Citrix Systems Inc in Q4 2022, selling an estimated $149M.
- Ergoteles's ten largest holdings make up 17% of its $2.72B portfolio in Q4 2022.
- Ergoteles opened 704 new positions and closed 800 in Q4 2022.
- Ergoteles's portfolio value fell 4.3% quarter-over-quarter to $2.72B.
Based on Ergoteles's 13F filing for Q4 2022, filed 14 Feb 2023.